[Optimize surveillance, prevention and control, vaccine strategies to respond to seasonal epidemics of respiratory infectious diseases].

The prevalence and evolution of respiratory pathogens are changing, and issues related to drug-resistance are becoming increasingly prominent in the post-COVID era. The urgency of controlling respiratory pathogens has intensified. This issue organizes expert discussions to address the resurgence of various respiratory pathogens, summarizing current status of pathogen surveillance, drug-resistance research and vaccine development, while suggesting countermeasures. It emphasizes the need to integrate of medical and preventive measures, conduct multi-pathogen surveillance and management, enhance the response capacity of respiratory infectious diseases, optimize vaccine policy and immunization services, improve the level of diagnosis and treatment, and strengthen protection for vulnerable populations, so as to reduce the burden of respiratory infectious diseases.